Literature DB >> 11086117

Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.

Fumihiro Taguchi1, Yohko K Shimazaki2,1.   

Abstract

The monoclonal antibody (MAb) 5B19.2, which has virus-neutralizing and fusion inhibition activities, binds to an epitope (S2A) consisting of nine hydrophobic amino acids in the S2 subunit of the mouse hepatitis virus (MHV) spike (S) protein. This suggests that the S2A epitope may be involved in binding the virus to the MHV receptor and/or in virus-cell fusion. Co-immunoprecipitation analyses demonstrated that while the binding of virus to the receptor was blocked by anti-S1 MAbs, it was not blocked by the S2A antiserum, indicating that S2A was not involved in receptor-binding. The S proteins prepared in this study with mutations in the S2A epitope were either fusogenic or non-fusogenic and their fusogenicity did not correlate with the hydrophobic feature of the S2A epitope. All of these wt and mutated S proteins were similarly transported onto the cell membrane independent of their fusogenicity capability. These results suggest that S2A may mediate the fusion activity of the MHV S protein during virus entry into cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086117     DOI: 10.1099/0022-1317-81-12-2867

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

Authors:  Kuo-Ming Lip; Shuo Shen; Xiaoming Yang; Choong-Tat Keng; Aihua Zhang; Hsueh-Ling Janice Oh; Zhi-Hong Li; Le-Ann Hwang; Chih-Fong Chou; Burtram C Fielding; Timothy H P Tan; Josef Mayrhofer; Falko G Falkner; Jianlin Fu; Seng Gee Lim; Wanjin Hong; Yee-Joo Tan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

3.  Receptor-induced conformational changes of murine coronavirus spike protein.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Emerging Technologies for the Treatment of COVID-19.

Authors:  Hossein Aghamollaei; Rahim Sarvestani; Hamid Bakherad; Hamed Zare; Paul C Guest; Reza Ranjbar; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein.

Authors:  Evelena Ontiveros; Taeg S Kim; Thomas M Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Authors:  Oliver Wicht; Christine Burkard; Cornelis A M de Haan; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.

Authors:  Rie Watanabe; Shutoku Matsuyama; Kazuya Shirato; Masami Maejima; Shuetsu Fukushi; Shigeru Morikawa; Fumihiro Taguchi
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Authors:  Hideka S Miura; Keiko Nakagaki; Fumihiro Taguchi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.

Authors:  Sandrine Belouzard; Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.